AA amyloidosis treated with tocilizumab: case series and updated literature review-Reference-Cited by-同舟云学术

AA amyloidosis treated with tocilizumab: case series and updated literature review

Published:2015-01-14 Issue:2 Volume:22 Page:84-92
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Courties Alice,Grateau Gilles,Philippe Peggy,Flipo René-Marc,Astudillo Leonardo,Aubry-Rozier Bérengère,Fabreguet Isabelle,Fahd Wafki,Fain Olivier,Guggenbuhl Pascal,Hachulla Eric,Papo Thomas,Richez Christophe,Sibilia Jean,Morel Jacques,Berenbaum Francis,Sellam Jérémie,

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/13506129.2014.1002031

Reference36 articles.

1. Molecular Mechanisms of Amyloidosis

2. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system

3. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein

4. Amyloidosis in autoinflammatory syndromes

5. Natural History and Outcome in Systemic AA Amyloidosis

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease;Annals of the Rheumatic Diseases;2024-04-23

2. AA Amyloidosis: A Contemporary View;Current Rheumatology Reports;2024-04-03

3. Vector autoregression: Useful in rare diseases?—Predicting organ response patterns in a rare case of secondary AA amyloidosis;PLOS ONE;2023-08-10

4. Editorial: The kidney in auto-immune and auto-inflammatory processes: Definitions, mechanisms, and biomarkers;Frontiers in Medicine;2023-01-10

5. AA amyloidosis of unknown aetiology: response to treatment with interleukin-1 inhibitors;Clinical Kidney Journal;2023-01-05